NIH invests $150 million in human-based research to reduce use of animal models
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Mar. 18, 2026, the National Institutes of Health (NIH) announced more than $150 million to develop and…
On Feb. 19, 2026, Phil and Penny Knight announced they have given a second transformational gift of $75 million…
On Feb. 12 2026, the Trump administration revoked a scientific finding that long has been the central basis…
On Feb. 6, 2026, a study led by researchers at Oxford Population Health reported that statins do not…
On Feb. 4, 2026, researchers from UT Southwestern Medical Center report that an experimental pill called enlicitide slashed…
On Jan. 13, 2026, The Vanderbilt Transplant Center had a banner year in 2024, setting a world record…
On Jan. 7, 2025, Eli Lilly and Ventyx Biosciences, a San Diego-based clinical-stage biopharmaceutical company focused on developing…
On Dec. 19, 2025, Cytokinetics announced that the U.S. Food and Drug Administration (FDA) has approved MYQORZO™ (aficamten),…
On Dec. 18, 2025, new national and state data was released by the Partnership to Fight Chronic Disease…
On Dec. 16, 2025, The largest-ever study testing the effectiveness of an evidence-based approach to increasing physical activity…
On Dec. 11, 2025, the California Institute for Regenerative Medicine (CIRM) governing board approved funding of over $160…
On Dec. 1, 2025, the World Health Organization (WHO) has released its first guideline on the use of…
On Nov. 20, 2025, the National Institutes of Health (NIH) has canceled funding for at least 383 clinical…
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
On Oct. 31, 2025, investigators from Mass General Brigham, the Broad Institute of MIT and Harvard, and VA…
On Oct. 29, 2025, Eli Lilly announced a planned investment of more than $1.2 billion to expand and…
On. Oct. 23, 2025, Air pollution continues to exacerbate global health, including noncommunicable diseases and dementia, according to…
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
On Sept. 10, 2025, philanthropist Melinda French Gates announces she will invest $50 million in a women’s health…
On Sept. 9, 2025, Novartis announced that it has entered into an agreement to acquire Tourmaline Bio, a…
On Jun. 11, 2025, a study led by by University of Barcelona experts Carles J. Ciudad and Verònica…
On May, 26, 2025, researchers in the Department of Biomedical Engineering at Texas A&M University announced they have…
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
On Mar. 3, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase),…
On Sept. 17, 2024, Boston Scientific announced the close of its acquisition of Silk Road Medical, a medical…
On Apr. 7, 2024, Edwards Lifesciences announced the release of data from the HUDDLE study that examined the…
On Mar. 20, 2024, a National Institutes of Health-supported study reported that SARS-CoV-2, the virus that causes COVID-19,…
On Nov. 17, 2023, Masimo announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter…